The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
Ariane van der StratenKawango AgotKhatija AhmedRachel WeinribErica N BrowneKgahlisho ManenzheFredrick OwinoJill SchwartzAlexandra Minnisnull nullPublished in: Journal of the International AIDS Society (2019)
In this population at risk for HIV and pregnancy, all participants agreed to choose and use a placebo MPT delivery form. A majority of participants preferred TRIO products to male condoms, an existing MPT. Injections were most liked and best used, however, they are years away from reaching the clinics. In the meantime, expanding the availability of tablets and giving access to rings can begin to fulfill the promise of choice for HIV prevention technologies and inform the development of suitable delivery forms as MPT.
Keyphrases
- antiretroviral therapy
- hiv positive
- pregnancy outcomes
- hiv testing
- hiv infected
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- preterm birth
- men who have sex with men
- platelet rich plasma
- primary care
- ultrasound guided
- polycystic ovary syndrome
- pregnant women
- south africa
- current status
- randomized controlled trial
- type diabetes
- metabolic syndrome
- middle aged
- decision making
- deep learning